
All eligible providers who do not participate in PQRS in 2013 will be subjected to a 1.5% penalty in 2015 and 2% penalty in 2016 and beyond. As you may be aware, there are many ways to participate in PQRS to avoid the 2015 penalty.

All eligible providers who do not participate in PQRS in 2013 will be subjected to a 1.5% penalty in 2015 and 2% penalty in 2016 and beyond. As you may be aware, there are many ways to participate in PQRS to avoid the 2015 penalty.

One way to structure health care information that you've accumulated in your electronic health record is to use standard instruments to measure the patient experience-often called patient-reported outcomes.

The likelihood of developing fibromyalgia and chronic fatigue syndrome increases over time in patients with urologic chronic pelvic pain syndromes (UCPPS), but only men seem to experience worsening of their urologic symptoms the longer the symptoms exist, according to analyses of the baseline characteristics of the Multidisciplinary Approach to Pelvic Pain (MAPP) study cohort.

Could bacteria in the lower urinary tract play a role in urologic chronic pelvic pain syndrome (CPPS)? The jury is still out, but the authors of a new study say they weren’t able to find any evidence that germs are at fault.

In a study of African-American men, researchers say they’ve linked two genetic variants to severity of lower urinary tract symptoms related to BPH, giving scientists insight into the higher risk facing African-Americans.

A new study has found that testosterone replacement doesn’t worsen lower urinary tract symptoms related to an enlarged prostate. In fact, many men saw their symptoms improve, apparently with little effect on their prostate gland.

Combining a prostate cancer gene assay with standard risk-stratification factors substantially increased information to guide decision making about active surveillance, a validation study of the assay showed.

Findings from a meta-analysis, including data from five independent patient cohorts, show that a novel genetic test is a powerful prognostic predictor of prostate cancer outcome across diverse clinical settings.

We’re all too familiar with the frustrations that come with the implementation of an EHR. As it turns out, though, practices frequently neglect the part of the system that gives you a return on your investment almost immediately: the patient portal.

The latest products and services from neoSurgical, Wiley-Blackwell, iURO, and USARAD.com.

Urology drugs and devices in the pipeline from AngioDynamics, Tetraphase Pharmaceuticals, Bellicum Pharmaceuticals, Competitive Technologies, Xion Pharmaceuticals, Jubilant Biosys, NewLink Genetics, Exosome Diagnostics, QIAGEN N.V., Aeterna Zentaris, and CureVac GmbH.

The University of Oklahoma College of Medicine, Oklahoma City has appointed Michael Shawn Cookson, MD, MMHC, as professor and chairman of the department of urology. He will hold the Donald Albers Endowed Chair in Urology.

Two new studies provide insights into aggressive prostate cancer that may suggest novel approaches to treatment.

A natural form of sugar could offer a new, noninvasive way to precisely image prostate and other tumors and potentially see whether cancer medication is effective, by means of a new imaging technology.

The tyrosine kinase inhibitors pazopanib (Votrient) and sunitinib (Sutent) had similar benefits in delaying progression of advanced renal cell carcinoma, but the safety profile and many measures of quality of life favored pazopanib, according to data from a recently published multicenter study.

Here’s how some of the ACA’s key provisions are shaping up and what to look for in the months ahead.

The advent of new biomarkers for prostate cancer could help determine the need for observation vs. interventional therapies.

Urologists discuss their preferred treatment approaches for advanced prostate cancer.

Urology Times Editorial Consultant Philip M. Hanno, MD, MPH, interviews Roger Dmochowski, MD, about his institution’s Patient Advocacy Reporting System as well as quality improvement and creating algorithms for appropriate care.

The transition to ICD-10 is not just another thing on urologists’ plates. It’s the main course, and time to prepare for the change is running short.

Prostate cancer aggressiveness may be established when the tumor is formed and does not alter with time, according to a recent study.

After 18 years of follow-up, new findings from the Prostate Cancer Prevention Trial show that the 5-alpha-reductase inhibitor finasteride (Proscar) reduces the risk of prostate cancer by about one-third but has no effect on mortality risk.

An analysis of data from a recent Government Accountability Office (GAO) explains why there is no health policy advantage to limiting where patients can choose to receive radiation oncology services for prostate cancer, according to the Large Urology Group Practice Association (LUGPA), which conducted the analysis.

Diabetic patients taking oral fluoroquinolones were found to have a higher risk of severe blood sugar-related problems than diabetic patients taking other kinds of antibiotics, according to a recently published study.

As follow-up lengthens in a prospective, randomized, controlled trial, men who underwent bipolar plasma vaporization of the prostate for BPH using the “button” vapo-resection electrode continue to demonstrate significantly better symptom scores and voiding characteristics compared to their counterparts treated by bipolar transurethral resection in saline or monopolar transurethral resection of the prostate.

Using genomic sequencing, researchers have confirmed a link between a plant compound contained in common herbal remedies and upper urinary tract cancer.

Testicular sperm extraction of frozen sperm taken by biopsy in azoospermic men is as effective as fresh sperm taken by biopsy in helping couples conceive through in vitro fertilization (IVF), according to a study from Washington University School of Medicine in St. Louis.

Patients who received their first kidney transplant at ages 14 to 16 years appear to be at increased risk for transplant failure, with African-American adolescents having a disproportionately higher risk of graft failure, new research shows.

A recently launched single-incision sling is designed with a visual feedback system that gives physicians the ability to objectively measure sling tension in a repeatable way to help find the most accurate placement for their patient.

With the advent of modern technology, it is easier than ever for physicians to take control of their financial situation. Whether you are researching investment options or performing financial planning retirement projections, online resources abound.